AEterna Zentaris To Present At Upcoming Biotechnology Industry Organization (BIO) CEO & Investor Conference In New York

QUEBEC CITY, Feb. 5 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. today announced that its President and Chief Executive Officer, Gilles Gagnon, will present a Company update at the 9th Annual BIO CEO & Investor Conference on Monday, February 12, 2007 at 11:00 a.m. Eastern, in the West Foyer of the Waldorf Astoria Hotel in New York City.

A live webcast of this presentation will be available on AEterna Zentaris' website at www.aeternazentaris.com in the Investors section. A replay will also be available for a period of 30 days.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a late-stage, global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at www.aeternazentaris.com.

AETERNA ZENTARIS INC.

CONTACT: Jenene Thomas, Senior Director, Investor Relations & CorporateCommunications, (418) 655-6420, jenene.thomas@aeternazentaris.com; PaulBurroughs, Media Relations, (418) 652-8525 ext. 406,paul.burroughs@aeternazentaris.com

MORE ON THIS TOPIC